Cited by 206Health Systems, Economic Evaluations, Quality of LifeDiabetes Treatment and ManagementDiabetes Management and Education

Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial

Open access
Simon, Judit, Gray, Alastair, Clarke, Philip, Wade, Alisha, Neil, Andrew, Farmer, Andrew·2008·BMJ

Abstract

OBJECTIVE: To assess the cost effectiveness of self monitoring of blood glucose alone or with additional training in incorporating the results into self care, in addition to standardised usual care for patients with non-insulin treated type 2 diabetes. DESIGN: Incremental cost utility analysis from a healthcare perspective. Data on resource use from the randomised controlled diabetes glycaemic education and monitoring (DiGEM) trial covered 12 months before baseline and 12 months of trial follow-up. Quality of life was measured at baseline and 12 months using the EuroQol EQ-5D questionnaire. SETTING: Primary care in the United Kingdom. PARTICIPANTS: 453 patients with non-insulin treated type 2 diabetes. INTERVENTIONS: Standardised usual care (control) compared with additional self monitoring of blood glucose alone (less intensive self monitoring) or with training in self interpretation of the results (more intensive self monitoring). MAIN OUTCOME MEASURES: Quality adjusted life years and healthcare costs (sterling in 2005-6 prices). RESULTS: The average costs of intervention were pound89 (euro113; $179) for standardised usual care, pound181 for less intensive self monitoring, and pound173 for more intensive self monitoring, showing an additional cost per patient of pound92 (95% confidence interval pound80 to pound103) in the less intensive group and pound84 ( pound73 to pound96) in the more intensive group. No other significant cost difference was detected between the groups. An initial negative impact of self monitoring on quality of life occurred, averaging -0.027 (95% confidence interval-0.069 to 0.015) for the less intensive self monitoring group and -0.075 (-0.119 to -0.031) for the more intensive group. CONCLUSIONS: Self monitoring of blood glucose with or without additional training in incorporating the results into self care was associated with higher costs and lower quality of life in patients with non-insulin treated type 2 diabetes. In light of this, and no clinically significant differences in other outcomes, self monitoring of blood glucose is unlikely to be cost effective in addition to standardised usual care. TRIAL REGISTRATION: Current Controlled Trials ISRCTN47464659.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmj.39526.674873.be

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [7]7. Owens DR, Barnett AH, Pickup J, Kerr D, Bushby P, Hicks D, et al. Blood glucose self-monitoring in type 1 and type 2 diabetes: reaching a multi-disciplinary consensus. Diabetes Primary Care 2004;6:398-402.
  2. [20]20. Department of Health. Review body of doctors' and dentists' renumeration: review for 2004. London: DoH, 2004.

Cited by

Sorted by citations

Authors
Simon, J., Gray, A., Clarke, P., Wade, A., Neil, A., & Farmer, A.
Affiliations
  • University of Oxford (GB)
  • The University of Sydney (AU)
  • Johns Hopkins University (US)
Corresponding author
Simon, Judit
Venue
BMJ
Publisher
BMJ
Published
2008-04-17
Volume
336
Issue
7654
Pages
1177-1180
ISSN
  • 0007-1447 (ISSN-L)
  • 0959-8138
  • 1468-5833
OpenAlex
W2021612182
Cited by
206
References
21
Citations by year
2026: 2 · 2025: 2 · 2024: 6 · 2023: 6 · 2022: 12 · 2021: 6 · 2020: 6 · 2019: 8 · 2018: 7 · 2017: 9 · 2016: 10 · 2015: 8 · 2014: 12 · 2013: 22 · 2012: 14
FWCI
57.52
Type
journal article
Language
en
Open access
Locations
  • BMJ (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Topics
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Keywords
self-monitoring of blood glucose, type 2 diabetes, non-insulin-treated diabetes, cost-effectiveness, patient education, quality of life, health care costs, quality-adjusted life years, primary care
MeSH terms
Adult, Aged, Cost-Benefit Analysis, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Hypoglycemia, Male, Middle Aged, Prognosis, Prospective Studies, Quality of Life, Blood Glucose Self-Monitoring, Quality-Adjusted Life Years

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review